Software for managing the risks and improving the profitability of pharmaceutical research
by John Gittins, Jiun-Yu Yu
International Journal of Technology Intelligence and Planning (IJTIP), Vol. 3, No. 4, 2007

Abstract: This paper presents software, and the stochastic model on which it is based, the purpose of which is to help decision makers to allocate resources during preclinical pharmaceutical research so as to improve risk management and profitability. Our model takes account of the successive stages of the research process, the possible non-linearity of the relationship between effort allocation and progress, discounting due to obsolescence, and competition between successive candidate drugs in a project, and its dependence on whether these are from the same or from different series of similar compounds. We shall show that it produces reasonable results, leading in some cases to a potentially dramatic improvement in profitability.

Online publication date: Sun, 16-Dec-2007

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology Intelligence and Planning (IJTIP):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com